Compare ATYR & DIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | DIT |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Distributors |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.2M | 70.9M |
| IPO Year | 2015 | 1995 |
| Metric | ATYR | DIT |
|---|---|---|
| Price | $0.88 | $112.99 |
| Analyst Decision | Hold | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $4.20 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 1.3K |
| Earning Date | 03-12-2026 | 01-19-2026 |
| Dividend Yield | N/A | ★ 0.89% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.63 |
| Revenue | $190,000.00 | ★ $2,273,870,361.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18,728.88 | N/A |
| P/E Ratio | ★ N/A | $69.19 |
| Revenue Growth | N/A | ★ 3.24 |
| 52 Week Low | $0.64 | $94.92 |
| 52 Week High | $7.29 | $145.00 |
| Indicator | ATYR | DIT |
|---|---|---|
| Relative Strength Index (RSI) | 54.93 | 55.77 |
| Support Level | $0.82 | $108.20 |
| Resistance Level | $0.94 | $113.85 |
| Average True Range (ATR) | 0.10 | 2.33 |
| MACD | 0.01 | 0.67 |
| Stochastic Oscillator | 54.37 | 86.70 |
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
Amcon Distributing Co is engaged in the wholesale and retail distribution of consumer products such as cigarettes, tobacco, confectionery, health food, and others. It operates in two segments: Wholesale distribution segment distributing consumer products to the retail outlets including convenience stores, grocery stores, liquor stores, drug stores and tobacco shops in the Central, Rocky Mountain, and Southern regions of the United States; and the Retail health food segment is a specialty retailer of natural/organic groceries and dietary supplements throughout the Midwest and Florida. The company earns a majority of the revenue from the Wholesale distribution segment.